Minimizing costs and maximizing efficiency while improving patient outcomes is critical for healthcare facilities around the world. This is especially true for healthcare organizations that support marginalized populations, including people of low socioeconomic status and indigenous communities.

Co-founders Dr. Raj Padwal, Dr. Jennifer Ringrose, and Peter Wood are clinical and academic experts in internal medicine, hypertension, cardiovascular risk factor management, epidemiology, and technology-assisted care. Their company offers digital remote monitoring solutions that allow users to monitor, share, and manage health data in a manner consistent with best clinical practice.

mmHg's Sphygmo smartphone/tablet app can be used to remotely monitor blood pressure, glucose levels, heart rate, weight, pulse oximetry, respiratory rate, and temperature. Available as a free download from the Apple App store and Google Play in English, French, Spanish, and Chinese, it's an easy way for clinicians and researchers to analyze and view data and engage patients.

A second product offered by mmHg is a cloud-based Ambulatory Blood Pressure Monitoring. It gives researchers a complete assessment of blood pressure and easier data analysis. Both platforms can be white-labelled to help organizations build their brand. They can also be integrated into mmGh's customers' own electronic medical / health record systems.

Key customers for these products include Federally Qualified Health Centers in the U.S. and academic institutions, including Johns Hopkins University, Beth Israel Deaconess Medical Center, Einstein Institute, and McGill University. Private labelling of core platforms has been under such monikers as Heart Track and Heart Track Pro, Tracky BP Pro, Precardix, Equate, and Sensly.

The team at mmHg also offers customized medical software development for researchers and companies. The goal is to help other companies leverage the expertise mmHg has developed creating its own products.

mmHg started in 2016 with one employee and has grown to 14 employees. Projections are to reach $1 million in revenue in 2022 and $2 million next year.

The company received funding from Alberta Innovates for market launch activities, including an AICE Market Access and Product Demonstration Program grant. It is currently active in Canada, the U.S., Hong Kong, and India. As of 2022, the company is planning its first external raise in the amount of $10 million. mmHg plans to expand its product range adding new data input offerings such as ECG, Holter, Lab Testing, and 2D Echocardiography, and will also expand to new international markets by searching for regional partners interested in private labelling.